239 related articles for article (PubMed ID: 20025540)
1. Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms.
Lubitz CC; Faquin WC; Yang J; Mekel M; Gaz RD; Parangi S; Randolph GW; Hodin RA; Stephen AE
Thyroid; 2010 Jan; 20(1):25-31. PubMed ID: 20025540
[TBL] [Abstract][Full Text] [Related]
2. Role of cytological and ultrasonographic features in predicting the risk of malignancy in thyroid nodules with indeterminate cytology.
Saiegh L; Shechner C; Dickstein G; Sheikh-Ahmad M; Reut M; Odeh M; Toubi A; Bejar J
Minerva Endocrinol; 2014 Mar; 39(1):43-52. PubMed ID: 24513603
[TBL] [Abstract][Full Text] [Related]
3. One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma.
Mihai R; Parker AJ; Roskell D; Sadler GP
Thyroid; 2009 Jan; 19(1):33-7. PubMed ID: 18976164
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy.
Williams MD; Suliburk JW; Staerkel GA; Busaidy NL; Clayman GL; Evans DB; Perrier ND
Ann Surg Oncol; 2009 Nov; 16(11):3146-53. PubMed ID: 19727961
[TBL] [Abstract][Full Text] [Related]
5. The impact of thyroid nodule size on the risk of malignancy and accuracy of fine-needle aspiration: a 10-year study from a single institution.
Shrestha M; Crothers BA; Burch HB
Thyroid; 2012 Dec; 22(12):1251-6. PubMed ID: 22962940
[TBL] [Abstract][Full Text] [Related]
6. Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration.
Tuttle RM; Lemar H; Burch HB
Thyroid; 1998 May; 8(5):377-83. PubMed ID: 9623727
[TBL] [Abstract][Full Text] [Related]
7. Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patients.
Rago T; Di Coscio G; Basolo F; Scutari M; Elisei R; Berti P; Miccoli P; Romani R; Faviana P; Pinchera A; Vitti P
Clin Endocrinol (Oxf); 2007 Jan; 66(1):13-20. PubMed ID: 17201796
[TBL] [Abstract][Full Text] [Related]
8. Malignancy risk assessment in adenomatoid nodules and suspicious follicular lesions of the thyroid obtained by fine needle aspiration cytology.
Dabelić N; Matesa N; Matesa-Anić D; Kusić Z
Coll Antropol; 2010 Jun; 34(2):349-54. PubMed ID: 20698101
[TBL] [Abstract][Full Text] [Related]
9. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
Elliott DD; Pitman MB; Bloom L; Faquin WC
Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of surgeon-performed ultrasound-guided fine-needle aspiration of thyroid nodules.
Bohacek L; Milas M; Mitchell J; Siperstein A; Berber E
Ann Surg Oncol; 2012 Jan; 19(1):45-51. PubMed ID: 21633868
[TBL] [Abstract][Full Text] [Related]
11. Role of surgeon-performed ultrasound in predicting malignancy in patients with indeterminate thyroid nodules.
Méndez W; Rodgers SE; Lew JI; Montano R; Solórzano CC
Ann Surg Oncol; 2008 Sep; 15(9):2487-92. PubMed ID: 18622644
[TBL] [Abstract][Full Text] [Related]
12. A risk model to determine surgical treatment in patients with thyroid nodules with indeterminate cytology.
Macias CA; Arumugam D; Arlow RL; Eng OS; Lu SE; Javidian P; Davidov T; Trooskin SZ
Ann Surg Oncol; 2015 May; 22(5):1527-32. PubMed ID: 25388058
[TBL] [Abstract][Full Text] [Related]
13. Examining the Bethesda criteria risk stratification of thyroid nodules.
Deniwar A; Hambleton C; Thethi T; Moroz K; Kandil E
Pathol Res Pract; 2015 May; 211(5):345-8. PubMed ID: 25796296
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors of malignancy in patients with cytologically suspicious for Hurthle cell neoplasm of thyroid nodules.
Lee KH; Shin JH; Ko ES; Hahn SY; Kim JS; Kim JH; Oh YL
Int J Surg; 2013; 11(9):898-902. PubMed ID: 23916366
[TBL] [Abstract][Full Text] [Related]
15. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
[TBL] [Abstract][Full Text] [Related]
16. Postoperative findings and risk for malignancy in thyroid nodules with cytological diagnosis of the so-called "follicular neoplasm".
Kim ES; Nam-Goong IS; Gong G; Hong SJ; Kim WB; Shong YK
Korean J Intern Med; 2003 Jun; 18(2):94-7. PubMed ID: 12872446
[TBL] [Abstract][Full Text] [Related]
17. Correlation of thyroid fine-needle aspiration with final histopathology: a case series.
Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M
Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233
[TBL] [Abstract][Full Text] [Related]
18. The impact of thyroid nodule size on the risk of malignancy in follicular neoplasms.
Ibrahim Y; Mohamed SE; Deniwar A; Al-Qurayshi ZH; Khan AN; Moroz K; Friedlander P; Kandil E
Anticancer Res; 2015 Mar; 35(3):1635-9. PubMed ID: 25750321
[TBL] [Abstract][Full Text] [Related]
19. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
[TBL] [Abstract][Full Text] [Related]
20. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]